Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence
about
Does zafirlukast reduce future risk of asthma exacerbations in adults? Systematic review and meta-analysisEvaluation of a physician-focused educational intervention on medicaid children with asthma.Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.Mild persistent asthma. Traits, treatment set it apart from mild intermittent asthma.New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.Asthma exacerbations . 4: Prevention.Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003.Leukotriene modifiers in the treatment of asthma in children.2003 canadian asthma consensus guidelines executive summary.Role of leukotriene receptor antagonists in the management of pediatric asthma: an update.The misuse of asthma drugs.Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.Asthma in children: management issues for family doctors.Step 4: stick or twist? A review of asthma therapy.Effects of the combined extracts of Herba Epimedii and Fructus Ligustrilucidi on airway remodeling in the asthmatic rats with the treatment of budesonide.Introduction of leukotriene receptor antagonists in ManitobaTreating allergic rhinitis and asthma: different sides of the same fence.Costs and resource use of mild persistent asthma patients initiated on controller therapy.Step 4: stick or twist? A review of asthma therapy.
P2860
Q26863510-D4EAF13F-3E00-4F15-97E3-4F76152D6CE7Q35762288-2F6FCCE2-3C29-4C08-A9DA-B76D4469772FQ35779312-18C294F5-C0D5-4F2B-B020-8F95D9B38DF3Q35788549-3191D501-FE7E-4A47-91EE-FACB745607F4Q35842492-A9B0DD7A-9FFD-414B-BF97-0E1E10E532FAQ36237953-6ADF0740-D84C-408E-A425-C948C3447316Q36255673-94C32B56-1990-45D8-9A33-5191B109876FQ37613312-B9CE3781-4A62-48F8-AF02-B23225C36921Q37763296-2CA3096C-952F-4917-9A5A-22D691B59AF2Q38034994-B682DB95-1544-40FA-B7DD-DF0E70A5FFD2Q38111795-15089751-FA35-4B93-AEF4-741B3E9E1289Q38172278-C5350DB1-7D26-4A8A-B43F-5AE982D50DC3Q38683202-B31745A4-EF55-43F3-8AEA-A3D4416E588BQ38960423-508FD23B-514D-40AE-8F63-ADECDCFED33EQ41215569-5D39EE15-BBD7-46FB-AFA3-7DA16449773CQ41904171-7CCBC372-325B-47B9-8783-338C9F761863Q43836540-5D420B05-7691-4A81-9851-8190496BEF39Q51887471-4D5DE6CE-396C-41FA-A28C-00F131C660F1Q54887789-8BF46332-BD40-43F8-93B3-65B9D56BB6DA
P2860
Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inhaled glucocorticoids versus ...... tic review of current evidence
@ast
Inhaled glucocorticoids versus ...... tic review of current evidence
@en
Inhaled glucocorticoids versus ...... tic review of current evidence
@nl
type
label
Inhaled glucocorticoids versus ...... tic review of current evidence
@ast
Inhaled glucocorticoids versus ...... tic review of current evidence
@en
Inhaled glucocorticoids versus ...... tic review of current evidence
@nl
prefLabel
Inhaled glucocorticoids versus ...... tic review of current evidence
@ast
Inhaled glucocorticoids versus ...... tic review of current evidence
@en
Inhaled glucocorticoids versus ...... tic review of current evidence
@nl
P2860
P356
P1433
P1476
Inhaled glucocorticoids versus ...... tic review of current evidence
@en
P2860
P356
10.1136/BMJ.326.7390.621
P407
P577
2003-03-01T00:00:00Z